Aptevo Therapeutics Inc.APVONASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank75
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-26.41M
↑ 26% vs avg
Percentile
P75
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-35.80M
Historical baseline
PeriodValueYoY Change
TTM$-26.41M-11.1%
2024$-23.78M+16.0%
2023$-28.31M-2.1%
2022$-27.74M-36.9%
2021$-20.26M+22.7%
2020$-26.19M+35.9%
2019$-40.83M+17.1%
2018$-49.27M+3.0%
2017$-50.82M+21.1%
2016$-64.40M-